Expertise in
37
conditions

Dr. Kevin S. Weibel

Oncology
The Cancer Center At SMC
1201 W 6th Ave, 
Stillwater, OK 
Accepting New Patients
Expertise in
37
conditions
The Cancer Center At SMC
1201 W 6th Ave, 
Stillwater, OK 

Overview

Kevin Weibel is an Oncologist practicing medicine in Stillwater, Oklahoma.

Dr. Weibel is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

She is actively involved in clinical research, participating in 4 clinical trials. Dr. Weibel is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in OK

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
CommunityCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

The Cancer Center at SMC
1201 W 6th Ave, Stillwater, OK 74074
Other Locations
Osu-AJ Tulsa Cancer Institute
12697 E 51st St, Tulsa, OK 74146

Additional Areas of Focus

Dr. Weibel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drugs: Ribociclib, Letrozole, Goserelin, Leuprolide
Study Phase: Phase 3
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Enrollment Status: Terminated
Publish Date: May 28, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Expertise in
80
conditions
Expertise in
80
conditions
Referral may be required

Mercy Hospital Oklahoma City Inc.

4300 W Memorial Rd, 
Oklahoma City, OK 
 (45.9 miles away)
405-751-4343
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Keefer is an Oncologist practicing medicine in Oklahoma City, Oklahoma. Dr. Keefer is highly rated in 80 conditions, according to our data. His clinical expertise encompasses Chondrosarcoma, Osteosarcoma, Ewing Sarcoma, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Keefer is currently accepting new patients.

Expertise in
54
conditions
Expertise in
54
conditions
Referral may be required

SSM Health Cancer Care

3525 N.W. 56th St., Suite 100D, 
Oklahoma City, OK 
 (49.5 miles away)
405-942-9200
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Board certified in both medical oncology and internal medicine, Aleda Toma, MD is a member of Cancer Specialists of Oklahoma, a part of SSM Health St. Anthony. She cares for patients in north Oklahoma City and surrounding areas, as well as Shawnee, Okla. Dr. Toma is highly rated in 54 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Toma is board certified in Oklahoma State Board Of Medical Licensure & Supervision, American Board Of Internal Medicine/Medical Oncology , American Board Of Internal Medicine , Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Toma is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

Ou Health Stephenson Cancer Center-Gynecologic Cancer Clinic

800 NE 10th St Ste 2100, 
Oklahoma City, OK 
 (50.4 miles away)
405-271-8707
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joan Walker is an Oncologist practicing medicine in Oklahoma City, Oklahoma. She has been practicing medicine for over 44 years. Dr. Walker is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Sertoli-Leydig Cell Tumor, Gamma Knife Radiosurgery, and Ureteroscopy. Dr. Walker is currently accepting new patients.

Frequently Asked Questions about Dr. Kevin S. Weibel

How do I make an appointment with Dr. Kevin S. Weibel?

You can book an appointment with Dr. Kevin S. Weibel by calling their office at 405-742-4930. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kevin S. Weibel a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kevin S. Weibel is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kevin S. Weibel specialize in?

While Dr. Kevin S. Weibel is a Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Kevin S. Weibel accept my insurance?

Dr. Kevin S. Weibel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 405-742-4930 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Weibel's expertise for a condition
ConditionClose
    View All 33 Advanced Conditions
    View All 107 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile